PA
Profund Advisors Portfolio holdings
AUM
$2.78B
This Quarter Return
+2.46%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.42B
AUM Growth
–
Cap. Flow
+$1.42B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
18.66%
Holding
1,386
New
1,386
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$40.4M |
| 2 |
Amgen
AMGN
|
$38.3M |
| 3 |
AbbVie
ABBV
|
$31.1M |
| 4 |
Exxon Mobil
XOM
|
$26.6M |
| 5 |
Biogen
BIIB
|
$26.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 23.48% |
| 2 | Technology | 11.48% |
| 3 | Financials | 10.21% |
| 4 | Energy | 9.8% |
| 5 | Consumer Discretionary | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $40.4M | 2.86% | +789,103 | New | +$40.4M |
|
|
2
Amgen
AMGN
$155B
| $38.3M | 2.7% | +387,978 | New | +$38.3M |
|
|
3
AbbVie
ABBV
$372B
| $31.1M | 2.2% | +751,991 | New | +$31.1M |
|
|
4
Exxon Mobil
XOM
$487B
| $26.6M | 1.88% | +294,785 | New | +$26.6M |
|
|
5
Biogen
BIIB
$19.4B
| $26.3M | 1.86% | +122,387 | New | +$26.3M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $25.2M | 1.78% | +215,635 | New | +$25.2M |
|
7
Apple
AAPL
$3.45T
| $23.1M | 1.63% | +58,215 | New | +$23.1M |
|
8
Microsoft
MSFT
$3.77T
| $17.9M | 1.27% | +519,123 | New | +$17.9M |
|
9
Johnson & Johnson
JNJ
$427B
| $17.7M | 1.25% | +205,888 | New | +$17.7M |
|
10
Alphabet (Google) Class C
GOOG
$2.58T
| $17.5M | 1.23% | +19,849 | New | +$17.5M |
|
11
Chevron
CVX
$324B
| $16.1M | 1.14% | +136,464 | New | +$16.1M |
|
12
Pfizer
PFE
$141B
| $13.3M | 0.94% | +476,148 | New | +$13.3M |
|
13
JPMorgan Chase
JPM
$829B
| $11.1M | 0.78% | +209,794 | New | +$11.1M |
|
14
Amazon
AMZN
$2.44T
| $11M | 0.78% | +39,699 | New | +$11M |
|
15
Wells Fargo
WFC
$263B
| $10.8M | 0.76% | +262,004 | New | +$10.8M |
|
16
Vertex Pharmaceuticals
VRTX
$100B
| $10.7M | 0.76% | +134,479 | New | +$10.7M |
|
17
Merck
MRK
$210B
| $10.1M | 0.71% | +216,549 | New | +$10.1M |
|
|
ALXN
18
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $9.34M | 0.66% | +101,244 | New | +$9.34M |
|
19
Intel
INTC
$107B
| $9.18M | 0.65% | +378,840 | New | +$9.18M |
|
20
Regeneron Pharmaceuticals
REGN
$61.5B
| $9.02M | 0.64% | +40,118 | New | +$9.02M |
|
21
AT&T
T
$209B
| $8.46M | 0.6% | +239,014 | New | +$8.46M |
|
22
Cisco
CSCO
$274B
| $8.45M | 0.6% | +347,386 | New | +$8.45M |
|
23
Oracle
ORCL
$635B
| $8.33M | 0.59% | +271,014 | New | +$8.33M |
|
24
Schlumberger
SLB
$55B
| $8.22M | 0.58% | +114,634 | New | +$8.22M |
|
25
Citigroup
C
$178B
| $7.76M | 0.55% | +161,686 | New | +$7.76M |
|